US-based electroceutical healthcare company electroCore has named Patrick Fabbio as chief financial officer.
Fabbio has over 20 years of financial leadership experience in public and private life science and pharmaceutical companies, most recently as VP finance for NPS Pharmaceuticals.
During his time at NPS, he led the build-out of the global finance department and supported its $5.2bn sale to Shire in February of this year.
Prior to NPS, Fabbio served in a range of senior financial positions including VP finance at Catalent Pharma Solutions, CFO at Ikano Therapeutics and senior corporate finance, commercial and transactional roles at Sanofi.
ElectroCore founder and CEO JP Errico commented: “I am delighted that Pat has joined the electroCore team. Pat is a senior executive with broad experience in general management and finance. He has a strong track record of success in corporate finance in the healthcare sector.”